ISSN: 2155-9570
Hamideh Shenazandi
West Indies
Research Article
Intravitreal Triamcinolone Injection as an Adjuvant to Standard Laser Therapy in Management of Proliferative Diabetic Retinopathy
Author(s): Hooshang Faghihi, Ahmad Mirshahi, Hamideh Shenazandi, Aalireza lashay, Mahnaz Abdollahian, Saied Dianat and Ali AbdollahiHooshang Faghihi, Ahmad Mirshahi, Hamideh Shenazandi, Aalireza lashay, Mahnaz Abdollahian, Saied Dianat and Ali Abdollahi
Purpose: To evaluate efficacy and safety of combined intravitreal triamcinolone acetonide (IVTA) injection plus panretinal photocoagulation (PRP) in comparison with PRP in proliferative diabetic retinopathy (PDR). Methods: 38 eyes of nineteen patients with PDR were enrolled. One eye of each patient was randomly selected to undergo IVTA injection one week prior to PRP session (IVTA eye), and contralateral eye treated with PRP alone (control eye). Patients were followed at 1, 4 and 6 months after treatment. Main outcome measures included change in logarithm of the minimum angle of resolution best-corrected visual acuity (logMAR BCVA), central macular thickness (CMT) and complications. Results: Mean baseline logMAR BCVA was 0.41±0.36 (IVTA eyes) and 0.36±0.30 (control eyes). At 6 months, Mean change of visual acui.. View More»
DOI:
10.4172/2155-9570.1000149